MarketCap
Facebook
X
TelegramGeschäftsbericht 2024
hinzugefügt 21.02.2026
Aptorum Group Limited DSO 2011-2026 | APM
DSO Jährlich Aptorum Group Limited
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 20.6 | 14.8 | 1.35 | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 20.6 | 1.35 | 12.2 |
DSO anderer Aktien in der Pharmaeinzelhändler
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
BioCardia
BCDA
|
101 | $ 1.36 | 5.04 % | $ 28.8 M |  USA |
 |
I-Mab
IMAB
|
271 | - | - | $ 866 M |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 | - | - | $ 40.3 B | USA |
 |
AgeX Therapeutics
AGE
|
78.4 | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
216 | - | - | $ 1.01 B | USA |
 |
BioXcel Therapeutics
BTAI
|
16.3 | $ 1.63 | -2.37 % | $ 4.13 M | USA |
 |
AbCellera Biologics
ABCL
|
173 | $ 3.65 | 0.97 % | $ 1.09 B |  Canada |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.114 | - | - | $ 26.5 M | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
204 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Can-Fite BioPharma Ltd.
CANF
|
28.1 | $ 4.83 | 1.68 % | $ 10.5 B |  Israel |
 |
Capricor Therapeutics
CAPR
|
31.9 | $ 26.89 | -3.72 % | $ 720 M | USA |
 |
Acorda Therapeutics
ACOR
|
48.3 | - | -24.86 % | $ 820 K | USA |
 |
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | Canada |
 |
Catalyst Biosciences
CBIO
|
3.24 | $ 11.55 | -4.47 % | $ 760 M | USA |
 |
Adverum Biotechnologies
ADVM
|
222 | - | - | $ 86.2 M | USA |
 |
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | USA |
 |
C4 Therapeutics
CCCC
|
27.9 | $ 3.04 | 12.59 % | $ 252 M | USA |
 |
Albireo Pharma
ALBO
|
14.7 | - | -0.23 % | $ 916 M | USA |
 |
Codexis
CDXS
|
32.9 | $ 1.08 | 6.93 % | $ 79.3 M | USA |
 |
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | USA |
 |
Cerus Corporation
CERS
|
59.2 | $ 2.64 | 2.93 % | $ 487 M | USA |
 |
Certara
CERT
|
89.6 | $ 7.17 | 1.2 % | $ 1.15 B | USA |
 |
Aeterna Zentaris
AEZS
|
146 | - | 5.93 % | $ 314 M | Canada |
 |
Compugen Ltd.
CGEN
|
60.8 | $ 2.24 | 23.76 % | $ 201 M | Israel |
 |
Coherus BioSciences
CHRS
|
263 | $ 1.66 | -0.9 % | $ 156 M | USA |
 |
Aravive
ARAV
|
16.8 | - | -13.39 % | $ 1.45 M | USA |
 |
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | USA |
 |
Celldex Therapeutics
CLDX
|
321 | $ 30.18 | 0.3 % | $ 2 B | USA |
 |
Cellectis S.A.
CLLS
|
94.5 | $ 3.88 | - | $ 116 M |  France |